首页|利用TCGA和GEPIA2公共数据库分析ACSM3与卵巢癌预后的关系

利用TCGA和GEPIA2公共数据库分析ACSM3与卵巢癌预后的关系

扫码查看
目的 研究肿瘤基因图谱(TCGA)数据库中酰基辅酶A合成酶中链家族成员 3(ACSM3)在 357 例卵巢癌患者中的表达量及其与患者生存状况的关系.方法 对TCGA数据库中 357 例卵巢癌患者的ACSM3 表达量及其与生存情况的关系进行分析,寻找其共表达基因并进行基因本体(GO)富集分析和京都基因与基因组百科全书(KEGG)富集分析.结果 多因素Cox回归分析进一步表明,ACSM3 是卵巢癌患者预后的影响因素,其共表达基因富集分析结果与炎症应答和肿瘤中基因异常转录相关.结论 ACSM3 的表达对卵巢癌患者的预后具有重要的意义,高表达预后较好.ACSM3 可以成为指导临床医师评估卵巢癌患者预后的重要指标.
Analysis on relationship between ACSM3 and ovarian cancer prognosis by TCGA and GEPIA2 public databases
Objective To investigate relationship between the expression levels of Acyl-CoA medium-chain synthetase 3(ACSM3)and the survival status of 357 patients with ovarian cancer in the cancer genome atlas(TCGA)database.Meth-ods The expression levels of ACSM3 and their relationship with survival conditions in 357 patients with ovarian cancer in TCGA database were analyzed,and co-expression genes of ACSM3 were searched for gene ontology(GO)enrichment analy-sis and Kyoto encyclopedia of genes and genomes(KEGG)enrichment analysis.Results Multivariate Cox regression analy-sis further indicated that ACSM3 was a prognostic factor for patients with ovarian cancer,and its co-expression gene enrich-ment analysis results were associated with inflammatory response and abnormal gene transcription in tumors.Conclusion The expression of ACSM3 is of great significance for the prognosis of patients with ovarian cancer,and high expression of it has better prognosis.ACSM3 can be an important indicator for guiding clinicians to evaluate the prognosis of patients with o-varian cancer.

Acyl-CoA medium-chain synthetase 3(ACSM3)the cancer genome atlas(TCGA)prognosisovarian cancer

侯娟、滕长财、王涛

展开 >

滨州医学院附属医院检验科,山东滨州 256603

酰基辅酶A合成酶中链家族成员3 肿瘤基因图谱 预后 卵巢癌

山东省自然科学基金

ZR2017PH014

2024

右江医学
右江民族医学院附属医院

右江医学

影响因子:0.779
ISSN:1003-1383
年,卷(期):2024.52(2)
  • 12